Category Archives: News

Ovarian Cancer Therapies in Development

Dr. Coleman, a member of the Alliance’s Scientific and Medical Advisory Board, conducted an interview on ovarian cancer therapies for the Cancer Network. He discussed the heterogeneity of ovarian cancer, … Continue reading 

| Leave a comment

Family History of Breast Cancer but no Genetic Mutation Does Not Raise Risk of Ovarian Cancer

Women with a family history of breast cancer but no BRCA1/2 mutation were found to be at average risk for developing ovarian cancer. The prospective study of 8005 women from … Continue reading 

| Leave a comment

Trebananib extends PFS in trials

A Phase III trial of a new molecule trebananib (also known as AMG 386) showed that women on the drug were 34 percent less likely to have their ovarian tumors … Continue reading 

| Leave a comment

Talcum Powder Raises Ovarian Cancer Risk by Almost One-Quarter

Regular application of talcum powder to a woman’s genital area appears to raise her risk of developing ovarian cancer by 24 percent, according to a new metanalysis. Read an article … Continue reading 

| Leave a comment

Report from ASCO 2013–What’s New in Ovarian Cancer Research

We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new … Continue reading 

Also posted in Blog | Leave a comment

June 2013 SNMMI Meeting

Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap … Continue reading 

| Leave a comment

New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer

A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use. See the … Continue reading 

| Leave a comment

Decreases in Ovarian Cancer Correlate to Decrease in Use of Hormone Replacement Therapy

A new study shows that rates of ovarian cancer decreased around the same time that the use of hormone replacement therapy dropped off. Overall, for women over 50, rates decreased … Continue reading 

| Leave a comment

Update on Treatment for Recurrent Ovarian Cancer

A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of … Continue reading 

| Leave a comment

Report from the American Association of Cancer Researchers Meeting

Ovarian cancer survivor Susan Leighton reports on her experience at the American Association of Cancer Researchers meeting, which took place in April 2013. For the second year in a row … Continue reading 

Also posted in Blog | Leave a comment

Endometriosis Treatments Lower Ovarian Cancer Risk

Women who had surgery to treat their endometriosis also lowered their risk of developing ovarian cancer. A study of approximately 600 Swedish women found that those who either had one … Continue reading 

| Leave a comment

Antidepressant May Help With Chemotherapy Side Effects

A study of 231 cancer patients found that the use of duloxetine (Cymbalta) reduced chemotherapy induce peripheral neuropathy. Patients either recieved Cymbalta or a placebo; in the Cymbalta arm, 59% … Continue reading 

| Leave a comment